Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use

Pedro Molina-Solana,1 Francisco de Borja Domínguez-Serrano,1 Antonio Manuel Garrido-Hermosilla,1,2 Jesús Montero-Iruzubieta,1,2 Ana Fernández-Palacín,3 Enrique Rodríguez-de-la-Rúa-Franch,1,2 Manuel Caro-Magdaleno1,2 1Ophthalmology, Vi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Molina-Solana P, Domínguez-Serrano FB, Garrido-Hermosilla AM, Montero-Iruzubieta J, Fernández-Palacín A, Rodríguez-de-la-Rúa-Franch E, Caro-Magdaleno M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/aa3bd5f48f4448d1903705c9dbf99a6c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa3bd5f48f4448d1903705c9dbf99a6c
record_format dspace
spelling oai:doaj.org-article:aa3bd5f48f4448d1903705c9dbf99a6c2021-12-02T08:13:40ZImproved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use1177-5483https://doaj.org/article/aa3bd5f48f4448d1903705c9dbf99a6c2020-04-01T00:00:00Zhttps://www.dovepress.com/improved-tear-film-stability-in-patients-with-dry-eye-after-hyaluronic-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Pedro Molina-Solana,1 Francisco de Borja Domínguez-Serrano,1 Antonio Manuel Garrido-Hermosilla,1,2 Jesús Montero-Iruzubieta,1,2 Ana Fernández-Palacín,3 Enrique Rodríguez-de-la-Rúa-Franch,1,2 Manuel Caro-Magdaleno1,2 1Ophthalmology, Virgen Macarena Hospital Seville, Seville, Spain; 2Surgery Department, University of Seville, Seville, Spain; 3Preventive Medicine and Public Health Department, University of Seville, Seville, SpainCorrespondence: Manuel Caro-Magdaleno Calle Bogotá 7, Bloque 3, 1ºB, Seville 41013, SpainTel +34 609030403Email mcaro79@gmail.comPurpose: Artificial tears only provide transient relief for dry eye. To the best of our knowledge, this is the first study to objectively compare treatment with artificial tears with Keratograph 5M, which allows accurate and objective investigation of dry eye and artificial tear treatment. We aimed to evaluate whether a preservative-free combination of 0.4% hyaluronic acid and 0.2% galactoxyloglucan can improve dry eye using the new topographer, Keratograph 5M.Patients and Methods: This prospective longitudinal, single-arm interventional cohort study was performed at a tertiary referral center and involved 20 patients with dry eye (40 eyes). Preservative-free artificial tears were administered every 3 h. The participants underwent clinical and instrumental evaluations at baseline, 15, 30, 60, 90 and 120 min after instillation and 1 week and 1 month after treatment. Baseline values were considered as the controls. All patients were assessed with Keratograph 5M for non-invasive Keratograph first break-up time and non-invasive Keratograph average break-up time, conjunctival hyperemia, and tear meniscus height. Ocular surface staining with fluorescein was evaluated using the slit-lamp and fluorescein break-up time examinations, and the Ocular Surface Disease Index score was recorded for each patient.Results: The signs and symptoms improved after 1 month of preservative-free 0.4% hyaluronic acid and 0.2% galactoxyloglucan treatment. There was a significant increase in the non-invasive Keratograph first break-up time and non-invasive Keratograph average break-up time at 15, 30, 60, and 90 min, and 1 week and 1 month (P < 0.05) and a decrease in hyperemia, corneal staining, and Ocular Surface Disease Index scores after 1 week and 1 month (P < 0.05). No treatment-related adverse event was observed.Conclusion: A combination of 0.4% hyaluronic acid and 0.2% galactoxyloglucan artificial tears seems effective for treating dry eye. Keratograph 5M can objectively detect these changes during the follow-up period.Keywords: artificial tears, Keratograph, non-invasive Keratograph break-up time, Ocular Surface Disease Index, dry eyeMolina-Solana PDomínguez-Serrano FBGarrido-Hermosilla AMMontero-Iruzubieta JFernández-Palacín ARodríguez-de-la-Rúa-Franch ECaro-Magdaleno MDove Medical Pressarticleartificial tearskeratographnon-invasive keratograph break-up timeocular surface disease indexdry eyeOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 1153-1159 (2020)
institution DOAJ
collection DOAJ
language EN
topic artificial tears
keratograph
non-invasive keratograph break-up time
ocular surface disease index
dry eye
Ophthalmology
RE1-994
spellingShingle artificial tears
keratograph
non-invasive keratograph break-up time
ocular surface disease index
dry eye
Ophthalmology
RE1-994
Molina-Solana P
Domínguez-Serrano FB
Garrido-Hermosilla AM
Montero-Iruzubieta J
Fernández-Palacín A
Rodríguez-de-la-Rúa-Franch E
Caro-Magdaleno M
Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
description Pedro Molina-Solana,1 Francisco de Borja Domínguez-Serrano,1 Antonio Manuel Garrido-Hermosilla,1,2 Jesús Montero-Iruzubieta,1,2 Ana Fernández-Palacín,3 Enrique Rodríguez-de-la-Rúa-Franch,1,2 Manuel Caro-Magdaleno1,2 1Ophthalmology, Virgen Macarena Hospital Seville, Seville, Spain; 2Surgery Department, University of Seville, Seville, Spain; 3Preventive Medicine and Public Health Department, University of Seville, Seville, SpainCorrespondence: Manuel Caro-Magdaleno Calle Bogotá 7, Bloque 3, 1ºB, Seville 41013, SpainTel +34 609030403Email mcaro79@gmail.comPurpose: Artificial tears only provide transient relief for dry eye. To the best of our knowledge, this is the first study to objectively compare treatment with artificial tears with Keratograph 5M, which allows accurate and objective investigation of dry eye and artificial tear treatment. We aimed to evaluate whether a preservative-free combination of 0.4% hyaluronic acid and 0.2% galactoxyloglucan can improve dry eye using the new topographer, Keratograph 5M.Patients and Methods: This prospective longitudinal, single-arm interventional cohort study was performed at a tertiary referral center and involved 20 patients with dry eye (40 eyes). Preservative-free artificial tears were administered every 3 h. The participants underwent clinical and instrumental evaluations at baseline, 15, 30, 60, 90 and 120 min after instillation and 1 week and 1 month after treatment. Baseline values were considered as the controls. All patients were assessed with Keratograph 5M for non-invasive Keratograph first break-up time and non-invasive Keratograph average break-up time, conjunctival hyperemia, and tear meniscus height. Ocular surface staining with fluorescein was evaluated using the slit-lamp and fluorescein break-up time examinations, and the Ocular Surface Disease Index score was recorded for each patient.Results: The signs and symptoms improved after 1 month of preservative-free 0.4% hyaluronic acid and 0.2% galactoxyloglucan treatment. There was a significant increase in the non-invasive Keratograph first break-up time and non-invasive Keratograph average break-up time at 15, 30, 60, and 90 min, and 1 week and 1 month (P < 0.05) and a decrease in hyperemia, corneal staining, and Ocular Surface Disease Index scores after 1 week and 1 month (P < 0.05). No treatment-related adverse event was observed.Conclusion: A combination of 0.4% hyaluronic acid and 0.2% galactoxyloglucan artificial tears seems effective for treating dry eye. Keratograph 5M can objectively detect these changes during the follow-up period.Keywords: artificial tears, Keratograph, non-invasive Keratograph break-up time, Ocular Surface Disease Index, dry eye
format article
author Molina-Solana P
Domínguez-Serrano FB
Garrido-Hermosilla AM
Montero-Iruzubieta J
Fernández-Palacín A
Rodríguez-de-la-Rúa-Franch E
Caro-Magdaleno M
author_facet Molina-Solana P
Domínguez-Serrano FB
Garrido-Hermosilla AM
Montero-Iruzubieta J
Fernández-Palacín A
Rodríguez-de-la-Rúa-Franch E
Caro-Magdaleno M
author_sort Molina-Solana P
title Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
title_short Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
title_full Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
title_fullStr Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
title_full_unstemmed Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
title_sort improved tear film stability in patients with dry eye after hyaluronic acid and galactoxyloglucan use
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/aa3bd5f48f4448d1903705c9dbf99a6c
work_keys_str_mv AT molinasolanap improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT dominguezserranofb improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT garridohermosillaam improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT monteroiruzubietaj improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT fernandezpalacina improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT rodriguezdelaruafranche improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
AT caromagdalenom improvedtearfilmstabilityinpatientswithdryeyeafterhyaluronicacidandgalactoxyloglucanuse
_version_ 1718398620338749440